|
Volumn 33, Issue 7-8, 2001, Pages 3450-
|
Neoral-based immunosuppression in living donor liver transplantation
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADOLESCENT;
ADULT;
ALAGILLE SYNDROME;
ARTICLE;
BILE DUCT ATRESIA;
CHILD;
CONTROLLED STUDY;
DISEASE COURSE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SCREENING;
FEMALE;
FOLLOW UP;
GLYCOGEN STORAGE DISEASE;
GRAFT REJECTION;
HISTOPATHOLOGY;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INFANT;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
LIVING DONOR;
MAJOR CLINICAL STUDY;
MALE;
NEWBORN HEPATITIS;
PRIMARY BILIARY CIRRHOSIS;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
WILSON DISEASE;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
AZATHIOPRINE;
CHILD;
CHILD, PRESCHOOL;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSION;
LIVER DISEASES;
LIVER TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
EID: 0035671864
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02487-3 Document Type: Article |
Times cited : (2)
|
References (4)
|